Abstract
In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Current Bioinformatics
Title: Intervention in Probabilistic Gene Regulatory Networks
Volume: 1 Issue: 2
Author(s): Aniruddha Datta, Ranadip Pal and Edward R. Dougherty
Affiliation:
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Abstract: In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Export Options
About this article
Cite this article as:
Datta Aniruddha, Pal Ranadip and Dougherty R. Edward, Intervention in Probabilistic Gene Regulatory Networks, Current Bioinformatics 2006; 1 (2) . https://dx.doi.org/10.2174/157489306777011978
DOI https://dx.doi.org/10.2174/157489306777011978 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers
Anti-Cancer Agents in Medicinal Chemistry Mesothelioma - Update on Management
Current Respiratory Medicine Reviews <i>In Vivo</i> Evaluation of Inorganic Nanoparticle Complexes against CCL<sub>4</sub> Induced Hepatotoxicity
Current Drug Delivery Strategies for Integral Metabolism Profile of Multiple Compounds in Herbal Medicines: Pharmacokinetics, Metabolites Characterization and Metabolic Interactions
Current Drug Metabolism A State-of-the-art Review and Prospective Therapeutic Applications of Prenyl Flavonoids as Chemosensitizers against Antifungal Multidrug Resistance in <i>Candida albicans</i>
Current Medicinal Chemistry Preface:
Current Topics in Medicinal Chemistry Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry MAVS: A New Weapon in the Fight Against Viral Infections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases
Current Pharmaceutical Design Trophoblast Invasion: A Possible Link Between Implantation Deficiencies and Preeclampsia
Current Women`s Health Reviews Computational and Statistical Methods to Explore the Various Dimensions of Protein Evolution
Current Bioinformatics Synthesis, Proton-Affinity and Anti-Cancer Properties of the Prodigiosin-Group Natural Products
Current Medicinal Chemistry - Anti-Cancer Agents Prodrugs in Genetic Chemoradiotherapy
Current Pharmaceutical Design Oncolytic Viruses for Induction of Anti-Tumor Immunity
Current Pharmaceutical Biotechnology Benzothiazole: A Versatile and Multitargeted Pharmacophore in the Field of Medicinal Chemistry
Letters in Organic Chemistry Epigenetic Modifications Due to Heavy Metals Exposure in Children Living in Polluted Areas
Current Genomics Induction of Senescent-Like Growth Arrest as a New Target in Anticancer Treatment
Current Cancer Drug Targets Electrotransfer into Skeletal Muscle for Protein Expression
Current Gene Therapy Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Co-delivery of Plasmid DNA and Antisense Oligodeoxyribonucleotide into Human Carcinoma Cells by Cationic Liposomes
Current Pharmaceutical Biotechnology